You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

deferoxamine

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Foot Ulcer Trial (Deferoxamine, Placebo)

Not yet recruiting
  • Diabetic Foot Ulcer
  • Deferoxamine
  • Placebo
  • (no location specified)
May 25, 2022

Ischemic Stroke, Acute Trial in Spain (Deferoxamine)

Completed
  • Ischemic Stroke, Acute
  • Deferoxamine
  • Badalona, Barcelona, Spain
  • +3 more
Aug 4, 2022

Aneurysmal Subarachnoid Hemorrhage Trial in Ann Arbor, Beijing (Deferoxamine, Placebo)

Recruiting
  • Aneurysmal Subarachnoid Hemorrhage
  • Deferoxamine
  • Placebo
  • Ann Arbor, Michigan
  • +1 more
Mar 28, 2022

Acute Kidney Injury Trial in Boston (Deferoxamine, Normal saline)

Recruiting
  • Acute Kidney Injury
  • Deferoxamine
  • Normal saline
  • Boston, Massachusetts
  • +2 more
Feb 3, 2022

Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in

Not yet recruiting
  • Brain Ischemia
  • Serum Iron
  • +7 more
  • Aswan, Egypt
    Aswan University Hospital
Mar 7, 2023

COVID19, Intensive Care Unit Trial in Ariana (Tocilizumab Injection, Deferoxamine)

Unknown status
  • COVID19
  • Intensive Care Unit
  • Tocilizumab Injection
  • Deferoxamine
  • Ariana, Tunisia
    Eshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Aria
Aug 26, 2020

Iron Overload, Oxidative Stress, Thalassemia Major Trial in Bani Suwayf, Mecca (Omega 3, Nigella Sativa Oil, Hydroxyurea)

Completed
  • Iron Overload
  • +2 more
  • Omega 3
  • +5 more
  • Banī Suwayf, Egypt
  • +3 more
Jan 25, 2021

Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone, Deferoxamine)

Terminated
Has Results
  • Iron Overload
  • +2 more
  • Oakland, California
  • +32 more
Jul 16, 2021

COVID-19 Trial in Kermanshah (Deferoxamine)

Unknown status
  • COVID-19
  • Deferoxamine
  • Kermanshah, Iran, Islamic Republic of
    Regenerative Medicine Research Center, Kermanshah University of
Apr 30, 2020

Intracerebral Hemorrhage Trial in Canada, United States (Deferoxamine, Normal saline)

Terminated
Has Results
  • Intracerebral Hemorrhage
  • Deferoxamine
  • Normal saline
  • Phoenix, Arizona
  • +28 more
May 29, 2019

Transfusion-dependent Hemachromatosis, Thalassemia Major, Sickle Cell Disease Trial in Boston (Deferoxamine, Deferasirox, HIDA)

Completed
Has Results
  • Transfusion-dependent Hemachromatosis
  • +2 more
  • Deferoxamine
  • +2 more
  • Boston, Massachusetts
    Children's Hospital Boston
Jun 14, 2019

Intracranial Aneurysm, Subarachnoid Hemorrhage Trial in Nijmegen, Groningen (Deferoxamine, )

Unknown status
  • Intracranial Aneurysm
  • Subarachnoid Hemorrhage
  • Deferoxamine
  • placebo
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Sep 26, 2017

Cardiovascular Diseases, Heart Diseases, Beta-Thalassemia Trial in United States (Deferoxamine, Deferiprone (L1))

Terminated
Has Results
  • Cardiovascular Diseases
  • +2 more
  • Deferoxamine
  • Deferiprone (L1)
  • Los Angeles, California
  • +5 more
Feb 1, 2018

Intracerebral Hemorrhage Trial in Beijing (deferoxamine, Xingnaojing injection, Normal saline)

Unknown status
  • Intracerebral Hemorrhage
  • deferoxamine
  • +2 more
  • Beijing, China
    Department of Neurology，Beijing Shijitan Hospital，Capital Medica
May 14, 2015

Transfusional Iron Overload, Transfusional Hemosiderosis Trial in Worldwide (Core Study: Deferasirox, Core Study: Deferoxamine,

Completed
Has Results
  • Transfusional Iron Overload
  • Transfusional Hemosiderosis
  • Core Study: Deferasirox
  • +5 more
  • Toronto, Ontario, Canada
  • +20 more
Aug 13, 2014

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

Completed
  • Anemia, Cooley's
  • +6 more
  • Deferoxamine
  • +4 more
  • Oakland, California
  • +4 more
Mar 3, 2014

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Boston (deferoxamine)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • deferoxamine
  • Boston, Massachusetts
  • +1 more
Apr 5, 2013

Beta-Thalassemia Trial in United States (ICL670, deferoxamine)

Completed
  • Beta-Thalassemia
  • Los Angeles, California
  • +6 more
Apr 18, 2012

Thalassemia Trial in New York (Deferoxamine, Deferasirox)

Unknown status
  • Thalassemia
  • New York, New York
    Weill Cornell Medical Center
Nov 4, 2010

Iron Overload, Cardiomyopathy Trial in Cagliari (Deferoxamine and Deferiprone, Deferoxamine)

Completed
  • Iron Overload
  • Cardiomyopathy
  • Deferoxamine and Deferiprone
  • Deferoxamine
  • Cagliari, Sardinia, Italy
    Adult Talassemic Center, Ospedale Microcitemico
Dec 1, 2008